SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-18-008949
Filing Date
2018-02-13
Accepted
2018-02-13 14:46:23
Documents
1
Group Members
AMIR L. ECKERCAROL G. FRANKENFIELD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5901_2sc13ga.htm SC 13G/A 113322
  Complete submission text file 0001104659-18-008949.txt   115181
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 18602479
SIC: 2834 Pharmaceutical Preparations

Mailing Address 555 E. LANCASTER AVE SUITE 540 RADNOR PA 19087
Business Address 555 E. LANCASTER AVE SUITE 540 RADNOR PA 19087 484-586-3513
ACT Capital Management, LLLP (Filed by) CIK: 0001442273 (see all company filings)

IRS No.: 141895400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A